Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2004

 

Commission File No. 0-16614

 

NEORX CORPORATION

(Exact name of Registrant as specified in its charter)

 

Washington

 

91-1261311

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer Identification No.)

 

300 Elliott Avenue West, Suite 500, Seattle, Washington 98119-4114

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (206) 281-7001

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes         ý            No           o

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act. 

 

Yes         ý            No           o

 

As of May 4, 2004, 30,376,010 shares of the Registrant’s common stock, $.02 par value per share, were outstanding.

 

 



 

TABLE OF CONTENTS

 

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2004

 

PART I
FINANCIAL INFORMATION
 
 
 
 

Item 1.

Financial Statements (Unaudited):

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2004and December 31, 2003

 

 

 

 

 

Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2004 and 2003

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2004 and 2003

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Results of Operations and Financial Condition

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

PART II
OTHER INFORMATION
 
 
 
 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

 

Signatures

 

 

 

 

 

Exhibit Index

 

 

2



 

PART I.  FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

NEORX CORPORATION AND SUBSIDIARY

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

(unaudited)

 

 

 

March 31, 2004

 

December 31, 2003

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

23,535

 

$

15,166

 

Investment securities

 

8,383

 

12,335

 

Prepaid expenses and other current assets

 

527

 

652

 

Total current assets

 

32,445

 

28,153

 

 

 

 

 

 

 

Facilities and equipment, net

 

7,369

 

7,471

 

Other assets, net

 

67

 

67

 

 

 

 

 

 

 

Total assets

 

$

39,881

 

$

35,691

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

672

 

$

409

 

Accrued liabilities

 

1,102

 

1,295

 

Current portion of note payable

 

389

 

385

 

Total current liabilities

 

2,163

 

2,089

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

Note payable, net of current portion

 

4,016

 

4,112

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred stock, $.02 par value, 3,000,000 shares authorized:

 

 

 

 

 

Convertible preferred stock, Series 1, 205,340 shares issued and outstanding at March 31, 2004 and December 31, 2003 (entitled in liquidation to $5,300 and $5,175, respectively, at March 31, 2004 and December 31, 2003)

 

4

 

4

 

Convertible preferred stock, Series B, 1,575 shares issued and outstanding at March 31, 2004 and December 31, 2003 (entitled in liquidation to $15,750)

 

 

 

Common stock, $.02 par value, 60,000,000 shares authorized, 30,054,175 and 28,002,945 shares issued and outstanding at March 31, 2004 and December 31, 2003, respectively

 

601

 

560

 

Additional paid-in capital

 

252,585

 

243,365

 

Accumulated deficit, including other comprehensive loss of $1 and $7 at March 31, 2004 and December 31, 2003, respectively

 

(219,488

)

(214,439

)

Total shareholders’ equity

 

33,702

 

29,490

 

Total liabilities and shareholders’ equity

 

$

39,881

 

$

35,691

 

 

See accompanying notes to the condensed consolidated financial statements.

 

3



 

NEORX CORPORATION AND SUBSIDIARY

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended March 31

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Revenues

 

$

500

 

$

116

 

Operating expenses:

 

 

 

 

 

Research and development

 

3,782

 

2,621

 

General and administrative

 

1,677

 

1,432

 

Total operating expenses

 

5,459

 

4,053

 

Loss from operations

 

(4,959

)

(3,937

)

Other income (expense):

 

 

 

 

 

Realized gain (loss) on sale of securities

 

 

16

 

Interest income

 

76

 

54

 

Interest expense

 

(47

)

(60

)

Total other income

 

29

 

10

 

Net loss before cumulative effect of change in accounting principle

 

(4,930

)

(3,927

)

Cumulative effect of change in accounting principle

 

 

(190

)

Net loss

 

(4,930

)

(4,117

)

Preferred stock dividends

 

(125

)

(125

)

Net loss applicable to common shares

 

$

(5,055

)

$

(4,242

)

 

 

 

 

 

 

Loss per share:

 

 

 

 

 

Basic and diluted loss per share applicable to common shares before cumulative effect of change in accounting principle

 

$

(0.17

)

$

(0.15

)

Cumulative effect of change in accounting principle

 

 

(0.01

)

Basic and diluted loss applicable to common shares

 

$

(0.17

)

$

(0.16

)

 

 

 

 

 

 

Weighted average common shares:

 

 

 

 

 

Basic and diluted

 

28,919

 

26,815

 

 

See accompanying notes to the condensed consolidated financial statements.

 

4